Showing results (231-240 of 333) with videos related to
Sort By:
Pageof 34
Blood Cancer Discovery|July 27, 2023
Next-Generation JAK2 Inhibitors for the Treatment of Myeloproliferative Neoplasms: Lessons from Structure-Based Drug Discovery ApproachesPramod C Nair, Jacob Piehler, Denis Tvorogov, et al.Blood Cancer Discovery|July 24, 2023
Time-Dependent Prognostic Value of Serological and Measurable Residual Disease Assessments after Idecabtagene VicleucelBruno Paiva, Irene Manrique, Julie Rytlewski, et al.Blood Cancer Discovery|March 26, 2026
Multiomic and Longitudinal Dissection of Immune Dynamics Associated with Parkinsonism after Ciltacabtagene Autoleucel TherapySofie-Katrin Kadel, Lukas Scheller, Alexander M Leipold, et al.Blood Cancer Discovery|April 17, 2026
A Phase 2, Open-Label, Multicenter Study of the Safety and Efficacy of TAK-007 in Adult Patients with Relapsed/Refractory B-cell Non-Hodgkin LymphomaJustin M Darrah, Indumathy Varadarajan, Amitkumar Mehta, et al.Blood Cancer Discovery|April 21, 2026
Outstanding Questions to Understand and Target Splicing Factor-Mutant Blood CancersMaxim I Maron, Omar Abdel-WahabBlood Cancer Discovery|April 14, 2026
3D chromosome remodeling in B-cell development and acute lymphoblastic leukemiaYohana E Ghebrechristos, Nikki A Evensen, Romane S Cathelin, et al.Blood Cancer Discovery|March 31, 2026
Models, Models, Everywhere: But Which One Should Guide Care?Curtis A Lachowiez, Sanam LoghaviBlood Cancer Discovery|August 10, 2026
Hattrick against Lymphoma with Trispecific CAR T CellsMaximilian Merz, Efrat LuttwakBlood Cancer Discovery|August 11, 2026
Predictive Models for Toxicities after CAR T-cell Therapy: Challenges and OpportunitiesJulie Ma, August Culbert, Tian-Gen Chang, et al.Blood Cancer Discovery|August 11, 2026
Glofitamab-Based Therapy for Relapsed or Refractory CNS Lymphoma: A Multicenter Retrospective StudyRuixian Xing, Apeng Yang, Juan Huang, et al.Pageof 34